Investing.com - Align reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Align announced earnings per share of $2.87 on revenue of $1.02B. Analysts polled by Investing.com anticipated EPS of $2.59 on revenue of $976.89M.
Align shares are down 5% from the beginning of the year , still down 18.00% from its 52 week high of $737.45 set on Thursday, September 23, 2021. They are under-performing the Nasdaq which is up 18.21% year to date.
Align shares gained 8.32% in after-hours trade the report.
Align follows other major Healthcare sector earnings this month
Align's report follows an earnings beat by J&J on Tuesday, October 19, 2021, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Thermo Fisher Scientific had beat expectations on Wednesday with third quarter EPS of $5.76 on revenue of $9.33B, compared to forecast for EPS of $4.68 on revenue of $8.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar